Bluefin Capital Management, LLC Bristol Myers Squibb CO Put Options Transaction History

Bluefin Capital Management, LLC

  • $1.3 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $1,300 - $768,400
10,000 New
10,000 $3,000
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $144,801 - $168,804
2,700 Added 11.11%
27,000 $1,000
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $775,127 - $907,961
13,100 Added 116.96%
24,300 $19,000
Q3 2020

Nov 16, 2020
BUY
$57.43 - $63.64 $643,216 - $712,768
11,200 New
11,200 $1,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bluefin Capital Management, LLC Portfolio

Follow Bluefin Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluefin Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email